Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Resectable NSCLC × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 3588 Carcinoma, Non-Small-Cell Lung 3541 Small Cell Lung Carcinoma 564 Breast Neoplasms 412 Neoplasms 299 Adenocarcinoma of Lung 247 Colorectal Neoplasms 217 Melanoma 197 Mesothelioma, Malignant 182 Prostatic Neoplasms 178 Brain Neoplasms 177 Pancreatic Neoplasms 175 Head and Neck Neoplasms 167 Neoplasm Metastasis 166 Ovarian Neoplasms 151 Esophageal Neoplasms 150 Mesothelioma 144 Colonic Neoplasms 139 Stomach Neoplasms 137 Pleural Effusion, Malignant 114 NSCLC 112 Carcinoma, Renal Cell 106 Urinary Bladder Neoplasms 105 Disease 86 Sarcoma 84 Uterine Cervical Neoplasms 79 Thymoma 78 Liver Neoplasms 77 Squamous Cell Carcinoma of Head and Neck 70 Motor Activity 70

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07492342 2026-03-25

K-NADIR

The First Affiliated Hospital of Guangzhou Medical University

Phase 2 Recruiting

Resectable NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡